Toward low-cost gene therapy: mRNA-based therapeutics for treatment of inherited retinal diseases.

Abstract excerpt

Inherited retinal diseases (IRDs) stem from genetic mutations that result in vision impairment. Gene therapy shows promising therapeutic potential, exemplified by the encouraging initial results with voretigene neparvovec. Nevertheless, the associated costs impede widespread access, particularly in low-to-middle income countries. The primary challenge remains: how can we make these therapies globally affordable?...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Genetic Therapy
• Share to Mutation
• Share to Retinal Diseases